Journal List HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSION Nicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Abstract previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectively Keywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesis Introduction Colon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro Like PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesis Materials Methods Mouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozyme Genetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examination Characterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomation Statistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groups Results Discussion PKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKC PKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cells PKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis models Acknowledgments authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CA Abbreviations used ACF aberrant crypt foci AOM azoxymethane hematoxylin eosin Footnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid References Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Journal List HHS Author Manuscripts PMC Journal List HHS Author Manuscripts PMC Journal List Journal List HHS Author Manuscripts HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer Learn disclaimer Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSION Nicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Abstract previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectively Keywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesis Introduction Colon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro Like PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesis Materials Methods Mouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozyme Genetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examination Characterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomation Statistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groups Results Discussion PKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKC PKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cells PKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis models Acknowledgments authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CA Abbreviations used ACF aberrant crypt foci AOM azoxymethane hematoxylin eosin Footnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid References Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSION Nicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Abstract previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectively Keywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesis Introduction Colon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro Like PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesis Materials Methods Mouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozyme Genetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examination Characterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomation Statistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groups Results Discussion PKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKC PKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cells PKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis models Acknowledgments authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CA Abbreviations used ACF aberrant crypt foci AOM azoxymethane hematoxylin eosin Footnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid References Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSION Nicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Abstract previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectively Keywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesis Introduction Colon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro Like PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesis Materials Methods Mouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozyme Genetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examination Characterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomation Statistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groups Results Discussion PKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKC PKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cells PKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis models Acknowledgments authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CA Abbreviations used ACF aberrant crypt foci AOM azoxymethane hematoxylin eosin Footnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid References Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSION Nicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi PMCID PMC NIHMSID NIHMS PMID Cancer Res Author manuscript available PMC Jan Published final edited form Cancer Res Jan doi CANCancer Res Author manuscript available PMC Jan Cancer ResPublished final edited form asPublished final edited form asCancer Res Jan doi CANCancer Res Jan doi CANdoi CANPMCID PMC NIHMSID NIHMS PMID PMCID PMCPMCID PMCNIHMSID NIHMSNIHMSID NIHMSPMID PROTEIN KINASE C II PKC COLLABORATING PARTNERS COLON CANCER PROMOTION PROGRESSIONNicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P FieldsNicole R Murray Justin Weems Ursula Braun Michael Leitges Alan P Fields Nicole R MurrayJustin WeemsUrsula BraunMichael LeitgesAlan P FieldsNicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R Murray Justin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin Weems Ursula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula Braun Michael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael Leitges Alan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P FieldsNicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R MurrayNicole R Murray Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Nicole R MurrayNicole R MurrayJustin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin WeemsJustin Weems Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Justin WeemsJustin WeemsUrsula Braun Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Ursula BraunUrsula Braun Biotechnology Centre Oslo University Oslo Oslo NorwayFind articles Ursula BraunUrsula BraunMichael Leitges Biotechnology Centre Oslo University Oslo Oslo Norway Find articles Michael LeitgesMichael Leitges Biotechnology Centre Oslo University Oslo Oslo NorwayFind articles Michael LeitgesMichael LeitgesAlan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P FieldsAlan P Fields Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Find articles Alan P FieldsAlan P FieldsAuthor information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Copyright notice Author information Copyright License information DisclaimerAuthor informationCopyright License informationDisclaimer Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleif ML APF contributed equally manuscript Department Cancer Biology Mayo Clinic College Medicine Jacksonville FL Biotechnology Centre Oslo University Oslo Oslo Norway correspondence addressed Alan P Fields PhD Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida Email udeoyamnalasdleif office Fax EMail udeoyamnalasdleifudeoyamnalasdleifudeoyamnalasdleif ML APF contributed equally manuscriptCopyright notice Copyright notice Copyright noticeAbstract previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectively Keywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesisAbstractWe previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectivelyWe previously demonstrated elevated expression either protein kinase CII PKCII PKC enhances colon carcinogenesis mice use novel bitransgenic mice determine relative importance PKCII PKC colon carcinogenesis two complimentary models colon cancer vivo Bitransgenic mice overexpressing PKCII constitutively active PKC PKCIIcaPKC kinasedeficient dominant negative PKC PKCIIkdPKC colon exhibit similar increase colon tumor incidence tumor size tumor burden response azoxymethane AOM compared nontransgenic littermates However PKCIIkdPKC mice develop predominantly benign colonic adenomas whereas PKCIIcaPKC mice develop malignant carcinomas contrast PKC deficient PKC mice fail develop tumors even presence caPKC previous data indicated PKCII drives tumorigenesis proliferation activating cateninApc signaling Consistent conclusion genetic deletion PKC effect spontaneous tumorigenesis APC min mice contrast tissuespecific knock PKC significantly suppresses intestinal tumor formation APC min mice data demonstrate PKCII PKC serve distinct nonoverlapping functions colon carcinogenesis PKCII required AOMinduced tumorigenesis dispensable tumor formation Apc Min mice PKC promotes tumor progression AOM APC min induced tumorigenesis Thus PKCII PKC whose expression elevated rodent human colon tumors collaborate drive colon tumor formation progression respectivelyin vivominminMinminKeywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesisKeywords colon carcinogenesis transgenic mice catenin proliferation Adenomatous polyposis coli Apc intestinal tumorigenesisIntroduction Colon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro Like PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesisIntroductionColon cancer third leading cause cancer death United States estimated new cases deaths Colon carcinogenesis multistep process involving progressive changes signaling pathways regulate colonic epithelial cell proliferation differentiation survival Prominent among changes involving PKC signaling pathways reviewed welldocumented colon carcinogenesis rodents humans accompanied specific changes expression PKC isozymes previously shown PKCII expression induced preneoplastic colonic aberrant crypt foci ACF tumors AOMtreated mice Elevated expression PKCII transgenesis induces colonic epithelial hyperproliferation increased susceptibility colon carcinogenesis PKCII overexpression induces decreased GSK activity increased catenin levels colonic epithelium vivo biochemical changes associated hyperproliferative phenotype mice PKCII also induces invasion intestinal epithelial cells via RasMek PKC Rac dependent signaling pathway vitro vivoin vitroLike PKCII PKC expression induced AOMmediated colon carcinogenesis Elevated PKC expression observed AOMinduced tumors ACF suggesting PKC may function later carcinogenic process PKC activity regulates susceptibility oncogenic Kras AOMmediated colon carcinogenesis transgenic mice expression constitutively active PKC allele colonic epithelium leads enhanced carcinogenesis AOM treatment Thus PKCII PKC play important roles colon carcinogenesis However functional relationship PKCII PKC signaling colon carcinogenesis explored Since overexpression either PKCII PKC enhance colon carcinogenesis possible PKC isozymes serve redundant functions carcinogenic process Alternatively PKC isozymes may collaborate coordinately enhance carcinogenesis present study examined relative contribution PKCII PKC AOMinduced colon carcinogenesis mutant APC Apc Min mediated intestinal tumorigenesis using compound transgenic mice results reveal PKCII PKC serve distinct nonoverlapping roles colon carcinogenesis conspiring drive initiation progression colon carcinogenesis respectively PKCII plays requisite role earliest stages carcinogeninduced colon carcinogenesis driving adenoma formation However PKCII dispensible Apc Min mediated tumorigenesis contrast PKC plays important role progression AOMinduced colon tumors adenoma carcinoma necessary Apc Min mediated tumorigenesisMinMinMinMaterials Methods Mouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozyme Genetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examination Characterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomation Statistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groupsMaterials MethodsMouse Breeding Maintenance Transgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozymeMouse Breeding MaintenanceTransgenic PKCII caPKC kdPKC mice express human PKCII constitutively active human PKC allele kinasedeficient dominant negative human PKC allele respectively colonic epithelium generated genotyped characterized transgene expression previously Mice nullizygous PKC PKC mice generated described previously Bitransgenic mice homozygous PKCII caPKC transgenes PKCIIcaPKC mice PKCII kdPKC transgenes PKCIIkdPKC mice homozygous caPKC transgene PKC knockout allele PKC caPKC mice generated breeding mice maintained CBL genetic background avoid potential strain differences phenotype Apc Min mice mice expressing Cre recombinase control mouse villin promoter Vilcre obtained Jackson Laboratory Floxed PKC PKC flfl mice expressing conditional Cre recombinaseinactivated PKC knock allele generated previously described Bitransgenic Apc Min PKC Apc Min PKC flfl mice tritransgenic Apc Min PKC flfl Vilcre mice generated breeding Mice housed microisolator cages pathogenfree barrier facility maintained constant temperature humidity h lighth dark cycle Mice provided standard irradiated rodent chow filtered water ad libitum throughout experiments noted term PKC refers human atypical PKC isoform derived PRKCI gene PKC refers mouse homolog human PKC term PKC used refer either mouse human atypical PKC isozymeMinflflMinMinflflMinflflad libitumPRKCIGenetic Analysis Transgenic Mice Genotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Genetic Analysis Transgenic MiceGenotypic analysis performed using protocols primer sets described following web sites presence loxP site PKC Cremediated recombination site detected PCR analysis described previously Carcinogen Exposure Tumor Analysis Transgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examinationCarcinogen Exposure Tumor AnalysisTransgenic mice enrolled standard azoxymethane AOM carcinogen protocol six weeks age described previously Briefly mice injected intraperitoneally mgkg AOM equal volume saline week four weeks Mice harvested weeks last AOM injection analysis Upon sacrifice colons isolated flushed cold saline slit open longitudinally fixed flat buffered formalin hours colons washed cold PBS stored ethanol C prior analysis Fixed colons stained briefly methylene blue evaluated presence tumors dissecting microscope using fold magnification location size tumor recorded Tumor volume calculated length width width Colon tumors isolated along adjacent normal epithelium processed histopathological examinationCharacterization Apc Min mediated intestinal tumor formation approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomationCharacterization Apc Min mediated intestinal tumor formationMinAt approximately six weeks age Apc Min Apc Min compound transgenic mice transferred standard rodent chow high fat breeder chow Teklad maintained diet sacrificed days age time sacrifice small intestine isolated divided evenly three sections ileum duodenum jejunum colon cecum rectum also isolated intestinal sections flushed cold PBS slit open longitudinally evaluated tumor formation Intestinal sections fixed flat formalin subjected immunohistochemistry deparaffinization rehydration sections processed antigen retrieval described manufacturer DAKO treated hydrogen peroxide methanol inhibit endogenous peroxidases catenin expression subcellular localization detected using mouse monoclonal anti catenin antibody BD Transduction Labs detected EnvisionDual Link DAB detection system DakoCytomationMinMinStatistical Analysis Fisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groupsStatistical AnalysisFisher Exact test used compare tumor incidence tTest used compare means tumor volume tumor burden experimental groupsResults Discussion PKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKC PKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cells PKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis modelsResults DiscussionPKCII promotes AOMinduced adenoma formation PKCindependent fashion previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shown Open separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg mice previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKCPKCII promotes AOMinduced adenoma formation PKCindependent fashionWe previously demonstrated transgenic PKCII mice overexpress PKCII intestinal epithelium susceptible AOMinduced colon carcinogenesis Consistent previous results transgenic PKCII mice exhibit statistically significant increase tumor incidence compared nontransgenic littermates Figure also implicated atypical PKC AOMinduced colon carcinogenesis vivo Since PKC important component least PKCIImediated signaling intestinal epithelial cells vitro possible PKC downstream effector PKCII colon carcinogenesis test hypothesis determined whether PKC required PKCII stimulate tumor formation response AOM using two bitransgenic mouse lines first bitransgenic line consisted mice overexpress PKCII constitutively active PKC transgene intestinal epithelium PKCIIcaPKC mice second line consisted mice express PKCII kinase deficient dominant negative PKC transgene intestinal epithelium PKCIIkdPKC mice Exposure two mouse lines AOM induced formation colon tumors similar incidence vs indistinguishable observed PKCII mice Figure B Though trend toward higher tumor incidence PKCIIcaPKC mice compared PKCII PKCIIcaPKC mice difference genotypes reach statistical significance Taken together data demonstrate PKCII plays prominent role tumor formation response AOM indicate PKCII dominant PKC process tumor formation directly assess point generated PKC knock mice PKC mice expressing constitutively active PKC caPKC intestinal epithelium PKC caPKC mice mice treated AOM failed form tumors Figure B demonstrating PKC absolutely required tumor formation PKC substitute PKCII process tumor initiation Quantitative PCR analysis PKC mice demonstrated mice exhibit selective loss PKC expression changes expression PKC PKC PKC data shownFigure AFigure vivoin vitroFigure BFigure BFigure BFigure BOpen separate window Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg miceOpen separate windowOpen separate windowOpen separate windowFigure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg miceFigure Figure PKCII drives formation growth AOMinduced tumors Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg micePKCII drives formation growth AOMinduced tumorsA Transgenic PKCII mice overexpressing PKCII colonic epithelium exhibit enhanced tumor incidence exposure azoxymethane AOM Fisher Exact test used compare tumor incidence genotypes Nontransgenic mice NonTg n transgenic PKCII mice PKCII n B Expression constitutively active PKC caPKC kinase deficient PKC kdPKC transgenic PKCII mice little effect tumor incidence induced PKCII PKC knock KO mice exhibit tumors even expressing caPKC PKCIIcaPKC n PKCIIdnPKC n PKC caPKC n C Transgenic PKCII mice expressing either caPKC kdPKC exhibit increased tumor volume C tumor burden compared nonTg miceABCDCDWe previously reported PKC plays critical role anchorageindependent growth human nonsmall cell lung cancer NSCLC cells vitro NSCLC tumorigenicity vivo Therefore possible PKC contributes growth PKCIIinitiated colon tumors AOMtreated mice test hypothesis assessed tumor volume tumor burden nontransgenic PKCIIcaPKC PKCIIkdPKC mice PKCIIcaPKC PKCIIkdPKC mice exhibited increase tumor volume Figure C tumor burden Figure compared nontransgenic littermates increase tumor volume burden PKCIIdnPKC PKCIIcaPKC mice significantly different though observed trend toward smaller tumors lower tumor burden PKCIIdnPKC mice data clearly indicate PKC plays relatively minor role growth PKCIIinitiated colon tumors previously demonstrated PKCII drives colon tumor formation stimulating proliferation colonic epithelial cells vivo current data demonstrate PKCII required AOMinduced colon carcinogenesis indicate PKCII promotes colon tumor formation promoting tumor proliferation manner largely independent PKC PKC hand plays relatively minor role tumor initiation growth presence elevated PKCII drive tumor formation absence PKCin vitroin vivoFigure CFigure CFigure DFigure Din vivoPKC drives adenoma carcinoma progression AOMinduced colon tumors initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Open separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cellsPKC drives adenoma carcinoma progression AOMinduced colon tumorsOur initial studies PKC isozyme expression AOMinduced colon carcinogenesis demonstrated PKCII expression induced early carcinogenesis process Elevated PKCII levels observed aberrant crypt foci ACF early preneoplastic lesions colon subsequent colon tumors also demonstrated PKC expression elevated AOMinduced tumors suggesting elevated PKC expression functionally linked colon carcinogenesis later stages model Consistent finding transgenic caPKC mice often develop intramucosal carcinomas rather adenomas treated AOM Therefore assessed whether PKC plays similar role tumor progression bitransgenic mice Pathologic analysis tumors PKCIIkdPKC PKCIIcaPKC mice treated AOM revealed PKCIIkdPKC mice developed predominantly benign adenomas tumors classified adenoma retaining significant tissue polarity cryptlike structure comparable produced nontransgenic mice Figure B sharp contrast majority tumors PKCIIcaPKC mice contained foci exhibiting progression malignant carcinoma p compared PKCIIkdPKC mice Colon carcinomas PKCIIcaPKC mice characterized presence disorganized sheets epithelial tumor cells disruption normal cryptlike glandular architecture loss basolateral apical cell polarity Figure C data consistent previous observation regarding PKC colon tumor progression Figure BFigure BFigure CFigure COpen separate window Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cellsOpen separate windowOpen separate windowOpen separate windowFigure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cellsFigure Figure PKC drives adenoma carcinoma progression AOMinduced colon tumors Representative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cellsPKC drives adenoma carcinoma progression AOMinduced colon tumorsRepresentative sections tumors nontransgenic NonTg PKCIIdnPKC B PKCIIcaPKC C mice stained hematoxylin eosin NonTg PKCIIkdPKC mice develop primarily adenomas retain cryptlike architecture epithelial cell polarity contrast tumors PKCIIcaPKC mice often carcinomas characterized loss crypt organization polarity formation disorganized sheets transformed tumor cellsABCPKCII dispensable intestinal tumorigenesis Apc Min mice PKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCII Open separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKCII dispensable intestinal tumorigenesis Apc Min miceMinPKCIIinduced intestinal epithelial cell proliferation associated activation APCcatenin proliferative signaling pathway characterized increased GSK activity stabilization catenin colonic epithelium vivo current data consistent hypothesis PKCII promotes AOMinduced tumorigenesis activating APCcatenin proliferative signaling pathway Transgenic PKCII mice exhibit decreased GSK activity colonic epithelium vivo consistent finding PKCII directly phosphorylate GSK Serine phosphorylation event inhibits GSK activity GSK inhibition leads stabilization catenin inhibiting APCmediated proteosomal degradation providing plausible mechanism PKCII stabilize catenin catenin critical effector PKCIImediated colon tumorigenesis one would predict requirement PKCII promote tumorigenesis might alleviated mice containing inactivating APC mutation serves stabilize catenin independent GSK test hypothesis crossed PKC Apc Min mice produce Apc Min PKC mice expected Apc Min PKC mice exhibit undetectable levels PKCII mRNA intestinal tract determined QPCR confirming lack PKC expression Figure contrast Apc Min mice express abundant PKCII mRNA intestine Figure Apc Min Apc Min PKC mice exhibited change expression PKC isozymes implicated colon tumorigenesis PKC PKC PKC Figure Tumor analysis revealed change number intestinal tumors two genotypes Figure B analysis tumor development colon small intestine separately also revealed change tumor number distribution organs Figure C Likewise significant change tumor number distribution within three major regions small intestine duodenum jejunum ileum mice Figure Analysis tumor burden average tumor size also revealed change genotypes data shown conclude PKC dispensable intestinal tumorigenesis Apc Min mice data consistent conclusion PKCII promotes AOMmediated colon carcinogenesis stabilizing catenin driving tumor proliferation whereas Apc Min mice catenin stabilized loss APC function thereby eliminating need PKCIIin vivoin vivoMinMinMinFigure AFigure AMinFigure AFigure AMinMinFigure AFigure AFigure BFigure BFigure CFigure CFigure DFigure DMinMinOpen separate window Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC Open separate windowOpen separate windowOpen separate windowFigure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC Figure Figure PKC dispensable tumor formation Apc Min mice Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC PKC dispensable tumor formation Apc Min miceMinA Bitransgenic Apc Min PKC mice exhibit profound loss PKC expression intestine Intestinal epithelium Apc Min Apc Min PKC mice isolated analyzed QPCR PKC PKCII PKC PKC mRNA abundance denotes p n B Apc Min Apc Min PKC mice develop equal numbers tumors throughout intestinal tract B Tumors Apc Min Apc Min PKC mice distributed pattern within colon small intestine C within subregions small intestine BD n Apc Min n Apc Min PKC AMinMinMinBDMinMinBMinMinCDBDMinMinPKC important intestinal tumorigenesis Apc Min mice next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarity Open separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock Apc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesis Open separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypes results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumors present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar function results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis modelsPKC important intestinal tumorigenesis Apc Min miceMinWe next assessed whether PKC plays role intestinal tumorigenesis Apc Min mice address question generated compound transgenic mouse line consisted Apc Min mice crossed mice harboring floxed PKC allele supports conditional Cre recombinasemediated inactivation PKC allele Apc Min PKC flfl mice Apc Min PKC flfl mouse crossed villinCre mouse expresses Crerecombinase constitutively intestinal tract control tissuespecific villin promoter produce Apc Min PKC flfl villin Cre mice Apc Min PKC flfl littermates cross served negative control experiments QPCR analysis intestinal epithelium isolated Apc Min PKC flfl mice Apc Min PKC flfl villin Cre mice demonstrated significant decrease PKC mRNA expression intestinal epithelium Apc Min PKC flfl villin Cre mice compared Apc Min PKC flfl mice Figure Despite loss PKC expression intestinal tract Apc Min PKC flfl villin Cre mice viable showed morbidity breeding problems intestinal epithelium mice exhibited obvious morphological changes crypt villus architecture polarity organization Figure B Furthermore basolateral membrane distribution intensity catenin intestine mice indistinguishable observed Apc Min PKC flfl mice Figure C Thus Cre mediated knock PKC intestinal epithelium obvious detrimental consequence intestinal epithelial tissue architecture function polarityMinMinMinflflMinflflMinflflMinflflMinflflMinflflMinflflMinflflFigure AFigure AMinflflFigure BFigure BMinflflFigure CFigure COpen separate window Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock outOpen separate windowOpen separate windowOpen separate windowFigure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock outFigure Figure Tissuespecific knock PKC overtly affect intestinal crypt architecture polarity Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock outTissuespecific knock PKC overtly affect intestinal crypt architecture polarityA Tissuespecific Crerecombinasemediated knockout PKC intestinal epithelium QPCR analysis RNA isolated intestinal epithelium Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrates loss PKC expression result Cremediated recombination denotes p n B C Apc Min PKC flfl B Apc Min PKC flfl villinCre C mice stained left panels reveals overt changes cryptvillus structure catenin staining right panels unchanged Apc Min PKC flfl villinCre mice compared Apc Min PKC flfl mice indicating cellular polarity disrupted PKC knock outAMinflflMinflflBCMinflflBMinflflCleft panelsleft panelsright panelsright panelsMinflflMinflflApc Min PKC flfl mice develop numerous tumors carpet intestinal epithelium Figure However Apc Min PKC flfl villin Cre mice develop significantly fewer intestinal tumors Apc Min PKC flfl mice Figure Interestingly Apc Min PKC flfl villinCre mice exhibited decrease tumor number small intestine colon Figure B unclear whether observation reflects differential function PKC colon small intestine due smaller number colon tumors induced colon model Apc Min PKC flfl villinCre mice developed fewer tumors regions small intestine indicating PKC important tumorigenesis throughout small intestine Figure C Pathologic immunohistochemical analysis tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice revealed genotypes produced adenomas exhibiting elevated expression nuclear localization catenin characteristic Apc Min phenotype Figure Thus data demonstrate PKC plays important role Apc Min tumorigenesisMinflflFigure AFigure AMinflflMinflflFigure AFigure AMinflflFigure BFigure BMinflflFigure CFigure CMinflflMinflflMinFigure DFigure DMinOpen separate window Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypesOpen separate windowOpen separate windowOpen separate windowFigure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypesFigure Figure Tissuespecific knock PKC inhibits tumorigenesis Apc Min mice Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypesTissuespecific knock PKC inhibits tumorigenesis Apc Min miceMinA Genetic deletion PKC inhibits intestinal tumorigenesis Apc Min PKC flfl mice develop numerous tumors throughout intestinal epithelium whereas Apc Min PKC flfl villinCre mice develop significantly fewer tumors throughout intestinal tract denotes p B Genetic deletion PKC inhibits tumor formation small intestine colon denotes statistically significant difference p C Deletion PKC inhibits tumorigenesis throughout small intestine p p AC n Apc Min PKC flfl mice n Apc Min PKC flfl villinCre mice catenin staining intestinal tumors Apc Min PKC flfl Apc Min PKC flfl villinCre mice demonstrating elevated expression nuclear localization tumor genotypesAMinflflMinflflBCACMinflflMinflflDMinflflMinflflOur results interesting light observed changes PKC isozyme expression AOM Apc Min induced carcinogenesis models previously demonstrated PKCII PKC expression elevated AOMinduced colon carcinogenesis albeit different kinetics current study demonstrates importance changes driving distinct complimentary aspects colon tumor development also observed loss PKC expression AOMinduced ACF tumors intestinal tumors APC min mice exhibit changes PKC isozyme expression similar observed AOMinduced colon tumors Specifically PKC PKC expression elevated intestinal tumors Apc Min mice whereas expression PKC PKC reduced tumors compared surrounding normal intestinal epithelium Although functional importance loss PKC expression yet elucidated AOM model colon carcinogenesis PKC loss drives tumorigenesis context Apc Min Nullizygous PKC PKC mice exhibit enhanced Apc Min mediated tumorigenesis spontaneous intestinal tumor formation absence Apc Min demonstrating PKC acts tumor suppressor intestinal tract contrast nullizygous PKC mice exhibited change susceptibility Apc Min mediated tumorsMinminMinMinMinMinMinOur present results demonstrate atypical PKC PKC play distinct nonredundant roles colon carcinogenesis Whereas PKC dispensable Apc Min mediated tumorigenesis PKC plays key role AOMand Apc Min induced carcinogenesis results consistent findings nonsmall cell lung cancer NSCLC shown PKC PKC specifically overexpressed human primary NSCLC tumors NSCLC cell lines Expression dominant negative kdPKC RNAimediated knock PKC expression leads inhibition anchorageindependent growth invasion NSCLC cell vitro loss NSCLC cell tumorigenicity vivo contrast RNAi mediated knock PKC effect either anchorageindependent growth invasion NSCLC cells studies indicate analysis PKC isozyme expression patterns various tumor models provides important clues role specific PKC isozymes tumorigenesis however transgenic models employed previous studies essential definitively investigate functional role individual PKC isozymes changes PKC isozyme expression physiologic pathologic processes vivo data also demonstrate first time two PKC isozymes implicated colon carcinogenesis PKCII PKC play distinct nonredundant roles colon tumorigenesis Furthermore data provide compelling evidence individual PKC isozymes often compensate loss another highly related PKC isozyme perform similar functionMinMinin vitroin vivoin vivoOur results important implications use therapeutic agents targeting PKC PKC isozymes since drugs targeting PKC isozymes currently evaluated clinical trials Enzastaurin potent selective small molecule inhibitor PKC shown clinical activity glioma Bcell lymphoma Enzastaurin also shown promise preclinical xenograft models hepatocellular carcinoma colon carcinoma results indicate Enzastaurin may also useful colon cancer particularly setting chemoprevention regard found colonic PKCII relevant target chemopreventive activity dietary fatty acids Enzastaurin extremely well tolerated making viable candidate chemopreventionchemointervention context high risk colon cancer patients However since APCcatenin mutations prevalent event sporadic familial colon cancers PKCdirected therapy may effective early chemoprevention strategies colon cancer prior acquisition activating mutation catenin loss Apc tumor suppressor activity contrast data indicate PKC may useful chemotherapeutic target treatment advanced colon cancers acquired Apccatenin andor Kras mutations shown PKC required oncogenic Kras mediated transformation colon lung vitro vivo present data demonstrate PKC also necessary Apcatenin mediated tumorigenesis vivo Since Kras catenin Apc mutations observed majority human colon cancers PKC inhibition may attractive strategy treatment tumors recently discovered novel small molecule inhibitor PKC aurothiomalate ATM shows good antitumor activity nonsmall cell lung cancer NSCLC preclinical models recently demonstrated elevated expression PKC NSCLC associated enhanced response PKCtargeted therapy ATM Since PKC expression elevated AOMinduced colon tumors tumors Apc Min mice primary human colon tumors tumors may also responsive PKCtargeted therapy Future studies required assess efficacy Enzastaurin ATM colon carcinogenesis modelsin vitroin vivoin vivoMinAcknowledgments authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CAAcknowledgmentsThe authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CAThe authors thank Ms Pam Krienest Brandy Edenfield tissue processing immunohistochemistry Ms Shelly Calcagno assistance expression analysis transgenic mice work supported part grants National Cancer Institute APF CA NRM CAAbbreviations used ACF aberrant crypt foci AOM azoxymethane hematoxylin eosinAbbreviations usedACF aberrant crypt foci AOM azoxymethane hematoxylin eosinACF aberrant crypt foci AOM azoxymethane hematoxylin eosinACF aberrant crypt foci AOM azoxymethane hematoxylin eosinACFaberrant crypt fociAOMazoxymethaneHEhematoxylin eosinFootnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolidFootnotes detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection mutant APC allele Apc Min mice httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolid detection VilCre transgene httpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolidAPCMinhttpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolidhttpjaxmicejaxorgpubcgiprotocolsprotocolsshobjtypeprotocolprotocolidReferences Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar References Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar Jemal Siegel R Ward E et al Cancer statistics CA Cancer J Clin PubMed Google Scholar CA Cancer J Clin CA Cancer J Clin PubMed Google Scholar Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar Fields AP Murray NR Gustafson WC Characterization role protein kinase C isozymes colon carcinogenesis using transgenic mouse models Methods Mol Biol PubMed Google Scholar Methods Mol Biol Methods Mol Biol PubMed Google Scholar Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar GokmenPolar Murray NR Velasco Gatalica Z Fields AP Elevated protein kinase C betaII early promotive event colon carcinogenesis Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Davidson LA Chapkin RS Clay Gustafson W Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar Zhang J Anastasiadis PZ Liu Thompson EA Fields AP Protein Kinase C II Induces Cell Invasion RasMEK PKCiotaRAC dependent Signaling Pathway J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Leitges Schmedt C Guinamard R et al Immunodeficiency protein kinase cbetadeficient mice Science PubMed Google Scholar Science Science PubMed Google Scholar Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar Liu Su W Thompson EA Leitges Murray NR Fields AP Protein kinase CbetaII regulates expression rat intestinal epithelial cells colonic epithelium vivo J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar Madison BB Dunbar L Qiao XT Braunstein K Braunstein E Gumucio DL Cis elements villin gene control expression restricted domains vertical crypt horizontal duodenum cecum axes intestine J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar Farese RV Sajan MP Yang H et al Musclespecific knockout PKClambda impairs glucose transport induces metabolic diabetic syndromes J Clin Invest PMC free article PubMed Google Scholar J Clin Invest J Clin Invest PMC free article PMC free articlePubMed Google Scholar Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems C Chen L et al Protein kinase C betaII TGFbetaRII omega fatty acidmediated inhibition colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar Goode N Hughes K Woodgett JR Parker PJ Differential regulation glycogen synthase kinase beta protein kinase C isotypes J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L et al Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Oncogene Oncogene PMC free article PMC free articlePubMed Google Scholar Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Fine HA Kim L Royce C Draper Haggarty Ellinzano H Albert P Kinney P Musib L Thorton Results phase II trial Enzastaurin LY patients recurrent high grade gliomas Journal Clinical Oncology ASCO Annual Meeting Proceedings p Google Scholar Google Scholar Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar Robertson MJ Kahl BS Vose JM et al Phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory diffuse large Bcell lymphoma J Clin Oncol PubMed Google Scholar J Clin Oncol J Clin Oncol PubMed Google Scholar Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Morschhauser F Seymour JF KluinNelemans HC et al phase II study enzastaurin protein kinase C beta inhibitor patients relapsed refractory mantle cell lymphoma Ann Oncol PubMed Google Scholar Ann Oncol Ann Oncol PubMed Google Scholar Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Graff JR McNulty Hanna KR et al protein kinase Cbetaselective inhibitor Enzastaurin LY HCl suppresses signaling AKT pathway induces apoptosis suppresses growth human colon cancer glioblastoma xenografts Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Guo K Liu Zhou H et al Involvement protein kinase C betaextracellular signalregulating kinase p mitogenactivated protein kinaseheat shock protein activation hepatocellular carcinoma cell motility invasion Cancer Sci PubMed Google Scholar Cancer Sci Cancer Sci PubMed Google Scholar Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar Carducci Musib L Kies MS et al Phase dose escalation pharmacokinetic study enzastaurin oral protein kinase C beta inhibitor patients advanced cancer J Clin Oncol PubMed Google Scholar J Clin Oncol J Clin Oncol PubMed Google Scholar Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar Welch PA Sinha VP Cleverly AL Darstein C Flanagan SD Musib LC Safety tolerability QTc evaluation pharmacokinetics single multiple doses enzastaurin HCl LY protein kinase Cbeta inhibitor healthy subjects J Clin Pharmacol PubMed Google Scholar J Clin Pharmacol J Clin Pharmacol PubMed Google Scholar Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar Erdogan E Lamark StallingsMann et al Aurothiomalate inhibits transformed growth targeting PB domain atypical protein kinase Ciota J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical Protein Kinase Ciota Expression Aurothiomalate Sensitivity Human Lung Cancer Cells Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google Scholar Formats PubReader PDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF Formats PubReader PDF PubReaderPubReaderPDF MPDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Cite Cite Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Create new collection Add existing collection Create new collection Create new collection Add existing collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Name collection Name must less characters Name collection Name must less characters Choose collection Unable load collection due error Please try Choose collection Unable load collection due error Please try Please try Add Cancel Add Cancel Share Permalink Copy Share Permalink Copy Permalink Copy Permalink Copy Permalink Copy Permalink Copy Copy Copy RESOURCES Similar articles Cited articles Links NCBI Databases RESOURCES Similar articles Cited articles Links NCBI Databases Similar articles Similar articles Similar articles Cited articles Cited articles Cited articles Links NCBI Databases Links NCBI Databases Links NCBI Databases